Position in GRAL
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$1,281,043
-$668,354 QoQ
Shares Held
24,788
+8.8% QoQ
Ownership
0.058%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GRAL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026PROFUND ADVISORS LLC holds $17,223,778 across 18 Diagnostics & Research names. GRAL ranks #7 (7.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IDXX |
Idexx Laboratories Inc /De
|
6,053 | $3,401,120 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
4,199 | $2,063,934 | |
| 3 | TWST |
Twist Bioscience Corp
|
43,039 | $2,045,213 | |
| 4 | NTRA |
Natera, Inc.
|
10,000 | $1,999,900 | |
| 5 | VCYT |
Veracyte, Inc.
|
48,774 | $1,571,010 | |
| 6 | DHR |
Danaher Corp /De/
|
7,032 | $1,333,267 | |
| 7 | GRAL |
GRAIL, Inc.
This page
|
24,788 | $1,281,043 | |
| 8 | CDNA |
CareDx, Inc.
|
35,217 | $611,367 |
All Filings in GRAL
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,281,043 | 24,788 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $1,949,397 | 22,776 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $558,305 | 9,442 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $448,382 | 8,720 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $307,833 | 12,053 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $183,158 | 10,261 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||